Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage 
Non-small Cell Lung Cancer

by Anhui SHI, Guangying ZHU
Published 2016-06-01

Stereotactic Radiotherapy for Non-small Cell Lung Cancer with Small Lesions
Applying A Flattening Filter Free Clinac

by Jianhao GENG, Anhui SHI, Rong YU, Hao WU, Guangying ZHU
Published 2015-05-01

A Randomized Phase I/II Trial to Compare Weekly Usage with Triple Weekly Usage of Paclitaxel in Concurrent Radiochemotherapy for Patients with Locally Advanced Non-small Cell Lung...

by Anhui SHI, Guangying ZHU, Rong YU, Yingjie WANG, Tingyi XIA
Published 2011-03-01

Application of Simultaneous Integrated Boost Intensity Modulated Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

by Jing YOU, Dan YANG, Dongming LI, Leilei JIANG, Rong YU, Huiming YU, Bo XU, Weihu WANG, Anhui SHI
Published 2019-11-01

Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer

by Jing YOU, Huiming YU, Maxiaowei SONG, Chen SHI, Xiaohang WANG, Ye ZHENG, Rong YU, Anhui SHI, Guangying ZHU
Published 2017-01-01

A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy 
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stag...

by Jing YOU, Huiming YU, Maxiaowei SONG, Chen SHI, Xiaohang WANG, Ye ZHENG, Rong YU, Anhui SHI, Guangying ZHU
Published 2017-01-01

Deficiencies in the Diagnosis and Treatment of Pulmonary Metastatic Osteosarcoma: 
A Chinese Multidisciplinary Survey

by Xiaozheng KANG, Zhen HUANG, Anhui SHI, Jie WANG, Dongmei LIN, Yingshi SUN, Guangying ZHU, Xiaohui NIU, Keneng CHEN
Published 2016-03-01

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT

by Junyue Shen, Dan Yang, Mailin Chen, Leilei Jiang, Xin Dong, Dongming Li, Rong Yu, Huiming Yu, Anhui Shi
Published 2021-06-01

Role of EGFR Mutation Status in Patients with Stage III Non-squamous Non-small Cell Lung Cancer Treated with Chemoradiotherapy

by Fuhai LI, Hua BAI, Xia’nan LI, Meina WU, Rong YU, Anhui SHI, Li YIN, Jie WANG, Guangying ZHU
Published 2011-09-01

Cone‐beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients

by Qingjin Qin, Anhui Shi, Ran Zhang, Qiang Wen, Tianye Niu, Jinhu Chen, Qingtao Qiu, Yidong Wan, Xiaorong Sun, Ligang Xing
Published 2020-04-01

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer

by Dan Yang, Jianing Cui, Jun Zhao, Jing You, Rong Yu, Huiming Yu, Leilei Jiang, Dongming Li, Bo Xu, Anhui Shi
Published 2020-03-01

Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers

by Xin Sui, Leilei Jiang, Huajing Teng, Lan Mi, Bo Li, Anhui Shi, Rong Yu, Dongming Li, Xin Dong, Dan Yang, Huiming Yu, Weihu Wang
Published 2021-02-01

Optimal first‐line treatment for advanced thymic carcinoma

by Xue Yang, Minglei Zhuo, Anhui Shi, Shengnan Yang, Ziping Wang, Meina Wu, Tongtong An, Yuyan Wang, Jianjie Li, Jia Zhong, Hanxiao Chen, Bo Jia, Zhi Dong, Jun Zhao
Published 2019-11-01

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

by Hongmei Lin, Yuhchyau Chen, Anhui Shi, Kishan J Pandya, Rong Yu, Yannan Yuan, Jiancheng Li, Hang Li, Yingjie Wang, Tingyi Xia, Linchun Feng, Huimin Ma, Jianhao Geng, Guangying Zhu
Published 2016-12-01

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study

by Anhui Shi, MD, Zhongxing Liao, MD, Pamela K. Allen, PhD, Linus Ho, MD, PhD, Mariela Blum Murphy, MD, Dipen M. Maru, MD, Stephen G. Swisher, MD, Wayne L. Hofstetter, MD, Reza J. Mehran, MD, James D. Cox, MD, Ritsuko Komaki, MD, Steven H. Lin, MD, PhD
Published 2017-07-01

Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial

by Nan Bi, Lipin Liu, Jun Liang, Shixiu Wu, Ming Chen, Changxing Lv, Lujun Zhao, Anhui Shi, Wei Jiang, Yaping Xu, Zongmei Zhou, Jingbo Wang, Wenqing Wang, Dongfu Chen, Zhouguang Hui, Jima Lv, Hongxing Zhang, Qinfu Feng, Zefen Xiao, Xin Wang, Tao Zhang, Weibo Yin, Junling Li, Jie He, Luhua Wang
Published 2020-04-01